Chances are, you or someone close to you has diabetes.
Diabetes affects more than 25 million Americans -- or about 8.3 percent of the population -- and about 346 million people worldwide, making it one of the most prevalent chronic health conditions.
In a study published last year, the U.S. Centers for Disease Control and Prevention projected that as many as one in three U.S. adults could have diabetes by 2050 if current trends continue.
Essential to managing diabetes properly is good blood glucose control, but many patients fail to achieve or maintain it. Despite the availability of many diabetes therapies, there is substantial unmet need for well-tolerated new treatments that provide sustained blood glucose control. A long-time innovator in the development of diabetes therapies, Bristol-Myers Squibb is building its pioneering role with compounds in development to address the unmet needs of patients with diabetes.